European Journal of Cancer

Formula-based dosing for carboplatin - bedside estimate
pp. 1299-1301(3)
Author: Jodrell D.I.

Rho-like GTPases - their role in epithelial cell-cell adhesion and invasion
pp. 1302-1308(7)
Authors: Sander E.E.; Collard J.G.

Should chemotherapy alone be the initial treatment for glottic squamous cell carcinoma? - preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group
pp. 1309-1310(2)
Authors: Mendenhall W.M.; Tannehill S.P.

Should chemotherapy alone be the initial treatment for glottic squamous cell carcinoma? - five-year results
pp. 1310-1312(3)
Author: Hotz M.A.

Should chemotherapy alone be the initial treatment for glottic squamous cell carcinoma? - is there a role?
pp. 1312-1313(2)
Authors: Kasler M.; Remenar E.

A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer
pp. 1314-1319(6)
Authors: Sculier J.P.; Paesmans M.; Thiriaux J.; Lecomte J.; Bureau G.; Giner V.; Koumakis G.; Lafitte J.J.; Berchier M.C.; Alexopoulos C.G.; Zacharias C.; Mommen P.; Ninane V.; Klastersky J.

The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial - evaluation of the prognostic role of the site of the primary tumour
pp. 1320-1325(6)
Authors: Veronesi U.; Marubini E.; Mariani L.; Valagussa P.; Zucali R.

Lack of correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal patients with early breast cancer
pp. 1326-1330(5)
Authors: Nomura Y.; Kataoka A.; Tsutsui S.; Murakami S.; Takenaka Y.

Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC gynaecological cancer cooperative group study - a Southwest Oncology Group study
pp. 1331-1337(7)
Authors: Pecorelli S.; Wagenaar H.C.; Vergote I.B.; Curran D.; Beex L.V.A.; Wiltshaw E.; Vermorken J.B.

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)
pp. 1338-1342(5)
Authors: Maindrault-Goebel F.; Louvet C.; Andre T.; Carola E.; Lotz J.P.; Molitor J.L.; Garcia M.L.; Gilles-Amar V.; Izrael V.; Krulik M.; de Gramont A.

CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer
pp. 1343-1347(5)
Authors: Andre T.; Louvet C.; Maindrault-Goebel F.; Couteau C.; Mabro M.; Lotz J.P.; Gilles-Amar V.; Krulik M.; Carola E.; Izrael V.; de Gramont A.

Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia - a report from the Children's Cancer Study Group
pp. 1349-1355(7)
Authors: von Stackelberg A.; Karatchunsky A.; Kudrjashova J.; Miakova N.; Belikova L.; Rumiantzev A.; Hartmann R.; Henze G.

Fetal rhabdomyomatous nephroblastoma - its morphology in patients under one year of age
pp. 1356-1360(5)
Authors: Maes P.; Delemarre J.; de Kraker J.; Ninane J.

Risk factors for breast cancer in women under 40 years - modeling temporal aspects of exposure
pp. 1361-1367(7)
Authors: Tavani A.; Gallus S.; La Vecchia C.; Negri E.; Montella M.; Dal Maso L.; Franceschi S.

Familial testicular cancer in a single-centre population*
pp. 1368-1373(6)
Authors: Sonneveld D.J.A.; Sleijfer D.T.; Schraffordt Koops H.; Sijmons R.H.; van der Graaf W.T.A.; Sluiter W.J.; Hoekstra H.J.

Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells - regulators of cell death
pp. 1374-1380(7)
Authors: Lee J.-U.; Hosotani R.; Wada M.; Doi R.; Kosiba T.; Fujimoto K.; Miyamoto Y.; Tsuji S.; Nakajima S.; Nishimura Y.; Imamura M.

Paracrine regulation of ovarian cancer by endothelin - vasoactive intestinal contractor peptide is rat endothelin-2
pp. 1381-1387(7)
Authors: Moraitis S.; Miller W.R.; Smyth J.F.; Langdon S.P.

Vitamin K₃ induces cell cycle arrest and cell death by inhibiting Cdc25 phosphatase
pp. 1388-1393(6)
Authors: Wu F.Y.-H.; Sun T.-P.

Effect of novel CAAX peptidomimetic farnesyltransferase inhibitor on angiogenesis in vitro and in vivo - targeting simply Ras?
pp. 1394-1401(8)
Authors: Gu W.-Z.; Tahir S.K.; Wang Y.-C.; Zhang H.-C.; Cherian S.P.; O'Connor S.; Leal J.A.; Rosenberg S.H.; Ng S.-C.

Influence of the schedule of exposure on the cytotoxic effect of melphalan on human 8226 and A2780 cells
pp. 1402-1406(5)
Authors: Pinguet F.; Bressolle F.; Culine S.; Fabbro M.; Astre C.; Chevillard C.

Comments on: Mutations in Mitochondrial Control Region DNA in Gastric Tumours of Japanese Patients, Tamura, et al. Eur J Cancer 1999, 35, 316-319
pp. 1407-1408(2)
Authors: Maximo V.; Soares P.; Seruca R.; Sobrinho-Simoes M.